Sep 27, 2023 · “With a biomarker test and MRI combined, the chance of missing a significant cancer is exceedingly low.” Urine tests: One urine test, EPI, is done using a fresh catch urine specimen. This test can help predict clinically significant prostate …

May 7, 2024 · Researchers developed a urine-based test that can distinguish between slow-growing prostate cancers that pose little risk and more aggressive cancers that need treatment. The test could help some patients avoid unnecessary biopsies and other tests that carry potential risks. Prostate cancer is a leading cause of cancer death among men nationwide.

3 days ago · “In the current study, this noninvasive urine test would have allowed patients with an elevated PSA to avoid 34%-53% of unnecessary biopsies.” MyProstateScore 2.0 (MPS2) urine test is a noninvasive test used to help identify high-grade prostate cancers that need early detection and treatment by analyzing 18 genes associated with prostate ...

2 days ago · MyProstateScore 2.0 (MPS2) urine test is a non-invasive test used to help identify high-grade prostate cancers that need early detection and treatment by analyzing 18 genes associated with ...

Apr 18, 2024 · The test, called MyProstateScore2.0, or MPS2, looks at 18 different genes linked to high-grade prostate cancer. In multiple tests using urine and tissue samples from men with prostate cancer, it successfully identified cancers classified as Gleason 3+4=7 or Grade Group 2 (GG2), or higher.

Jan 29, 2025 · A urine-based test, MyProstateScore 2.0 (MPS2), has been clinically validated to detect aggressive prostate cancer without the need for invasive procedures like biopsies.

Apr 18, 2024 · The urine test, MyProstateScore 2.0 (MPS2), was shown to meaningfully reduce unnecessary prostate biopsies while providing highly accurate detection of worrisome prostate cancers, the researchers concluded.

Apr 24, 2024 · The prostate cancer urine test assesses 18 genes linked to high-grade prostate cancer—cancers that are more likely to grow and spread. It targets cancers classified as Gleason 3+4=7 or Grade Group 2 (GG2) or higher.

May 6, 2024 · In April, researchers at the University of Michigan published results with a test that screens for prostate cancer in urine samples. Called the MyProstateScore 2.0 (MPS2) test, it looks for 18 different genes associated with high-grade tumors.

Jan 30, 2025 · The results were published in the Journal of Urology.. The urine-based test was previously validated and shown to be effective in identifying GG2 or higher cancers in a study published in April 2024. 2 That study, however, used urine samples that were obtained following a digital rectal exam (DRE). “The process requires the prostate to be compressed, causing the release of cellular debris ...